Skip to main content

FDA approves sunitinib malate as adjuvant treatment for RCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA approves sunitinib malate as adjuvant treatment for RCC

User login

Username

Password

Reset your password

Type	Lead	score